Home / Brands / Harbin Jixianglong Biotech
Harbin Jixianglong Biotech Recalls
2 recalls on record · March 11, 2026 to March 11, 2026 · Drugs
March 11, 2026DrugsFDA
Harbin Jixianglong Biotech Co., Ltd. recalls Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 843
Hazard: CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
March 11, 2026DrugsFDA
Harbin Jixianglong Biotech Co., Ltd. recalls Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 8438
Hazard: CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution